Cargando…
Harmonization of Newborn Screening Results for Pompe Disease and Mucopolysaccharidosis Type I
In newborn screening, false-negative results can be disastrous, leading to disability and death, while false-positive results contribute to parental anxiety and unnecessary follow-ups. Cutoffs are set conservatively to prevent missed cases for Pompe and MPS I, resulting in increased falsepositive re...
Autores principales: | Dorley, M. Christine, Dizikes, George J., Pickens, Charles Austin, Cuthbert, Carla, Basheeruddin, Khaja, Gulamali-Majid, Fizza, Hetterich, Paul, Hietala, Amy, Kelsey, Ashley, Klug, Tracy, Lesko, Barbara, Mills, Michelle, Moloney, Shawn, Neogi, Partha, Orsini, Joseph, Singer, Douglas, Petritis, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059896/ https://www.ncbi.nlm.nih.gov/pubmed/36975849 http://dx.doi.org/10.3390/ijns9010011 |
Ejemplares similares
-
Multiplexing Iduronate-2-Sulphatase (MPS-II) into a 7-Plex Lysosomal Storage Disorder MS/MS Assay Using Cold-Induced Phase Separation
por: Courtney, Elya, et al.
Publicado: (2023) -
Harmonizing Newborn Screening Laboratory Proficiency Test Results Using the CDC NSQAP Reference Materials
por: Pickens, Charles Austin, et al.
Publicado: (2020) -
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases
por: Belfiore, Maria Paola, et al.
Publicado: (2020) -
Liquid Chromatography–Tandem Mass Spectrometry in Newborn Screening Laboratories
por: Gelb, Michael H., et al.
Publicado: (2022) -
Newborn Screening for Pompe Disease in Illinois: Experience with 684,290 Infants
por: Burton, Barbara K., et al.
Publicado: (2020)